Literature DB >> 368637

Drug therapy: vasodilator drugs in peripheral vascular disease.

J D Coffman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 368637     DOI: 10.1056/NEJM197903293001305

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  23 in total

Review 1.  Pharmacological treatment of patients with peripheral arterial disease.

Authors:  Chin K Kim; Carsten M Schmalfuss; Richard S Schofield; David S Sheps
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 2.  Current strategies in the diagnosis and management of lower extremity peripheral vascular disease.

Authors:  T J Wilt
Journal:  J Gen Intern Med       Date:  1992 Jan-Feb       Impact factor: 5.128

3.  Pentoxifylline in arterial disease of the legs.

Authors:  R Verhaeghe; M Verstraete
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 4.  The behavioral treatment of Raynaud's disease: a review.

Authors:  G D Rose; J G Carlson
Journal:  Biofeedback Self Regul       Date:  1987-12

5. 

Authors:  C Diehm; H Heidrich; F Spengel; K L Schulte; W Theiss
Journal:  Internist (Berl)       Date:  2000-11       Impact factor: 0.743

6.  Raynaud's disease.

Authors:  E C Burns; D B Dunger; M J Dillon
Journal:  Arch Dis Child       Date:  1985-06       Impact factor: 3.791

Review 7.  Intermittent claudication. An update on management.

Authors:  P A Blombery
Journal:  Drugs       Date:  1987-09       Impact factor: 9.546

8.  Clinical and laboratory effects of nifedipine in Raynaud's phenomenon.

Authors:  S J Hawkins; C M Black; N D Hall; A McGregor; E F Ring; P J Maddison
Journal:  Rheumatol Int       Date:  1986       Impact factor: 2.631

9.  Prostaglandin E1 infusions for vascular insufficiency in progressive systemic sclerosis.

Authors:  M F Martin; P M Dowd; E F Ring; E D Cooke; P A Dieppe; J D Kirby
Journal:  Ann Rheum Dis       Date:  1981-08       Impact factor: 19.103

Review 10.  Naftidrofuryl for intermittent claudication: meta-analysis based on individual patient data.

Authors:  T De Backer; R Vander Stichele; P Lehert; L Van Bortel
Journal:  BMJ       Date:  2009-03-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.